Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary Arteries

References

• Folts J D, Gallagher K, Rowe G G. Blood flow reduction in stenosed canine coronary arteries: vasospasm or platelet aggregation?. Circulation 1982; 65: 248–255
   PubMed Web of Science ®Google Scholar
• Willerson J T, Hillis L D, Winniford M, Buja L M. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol 1986; 8: 245–250
   PubMed Web of Science ®Google Scholar
• Fitzgerald D J, Roy L, Catella F G, FitzGerald G A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–989
   PubMed Web of Science ®Google Scholar
• Fuster V, Chesebro J H. Mechanics of unstable angina. N Engl J Med 1986; 315: 1023–1025
   PubMed Web of Science ®Google Scholar
• Taylor F B, Jr, Muller-Eberhard J H. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in aggregation and retraction of platelets. J Clin Invest 1970; 49: 2068–2085
   Google Scholar
• Lockhart M, Comp P C, Taylor E B, Jr. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets. J Lab Clin Med 1979; 94: 285–294
   Google Scholar
• Carroll R C, Gerrard J M, Gilliam J M. Clot retraction facilitates clot lysis. Blood 1981; 57: 44–48
   Google Scholar
• Carroll R C, Radcliffe R D, Taylor F B, Jr, Gerrard J M. Plasminogen plasminogen activator, and platelets in the regulation of clot lysis. J Lab Clin Med 1982; 100: 986–996
   Google Scholar
• Miles L A, Plow E F. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303–4311
   PubMedGoogle Scholar
• Miles L A, Ginsberg M H, White J G, Plow E F. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001–2009
   PubMedGoogle Scholar
• Park S, Harker L S, Marzec U M, Levin E G. Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. Blood 1989; 73: 1421–1425
   PubMed Web of Science ®Google Scholar
• Erickson L A, Ginsberg M H, Loskutoff D J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465–1472
   PubMed Web of Science ®Google Scholar
• Niewiarowski S, Senyi A F, Gillies P. Plasmin-induced platelet aggregation and platelet release reaction. J Clin Invest 1973; 52: 1647–1659
   PubMedGoogle Scholar
• Miller J L, Katz A J, Feinstein M B. Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diath Haemorrh 1975; 33: 286–309
   PubMedGoogle Scholar
• Adelman B, Michelson A D, Loscalzo J, Greenberg J, Handin R I. Plasmin effect on platelet glycoprotein Ib-von Willebrand's factor interactions. Blood 1985; 65: 32–40
   PubMed Web of Science ®Google Scholar
• Strieker R B, Wong D, Shiu D T, Reyes P T, Shuman M A. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: Effects on surface proteins and platelet aggregation. Blood 1986; 68: 275–280
   Google Scholar
• Schafer A I, Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest 1985; 75: 456–461
   PubMed Web of Science ®Google Scholar
• Schafer A I, Maas A K, Ware J A, Johnson P C, Rittenhouse S E, Salzman E W. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J Clin Invest 1986; 78: 73–79
   PubMedGoogle Scholar
• Schafer A I, Zavoico G B, Loscalzo J, Maas A K. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2. Blood 1987; 69: 1504–1507
   PubMedGoogle Scholar
• Ohlstein E H, Storer B, Fujita T, Shebuski R J. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit. Thromb Res 1987; 46: 575–585
   PubMedGoogle Scholar
• Fitzgerald D J, Catella F, Roy L, FitzGerald G A. Marked platelet activation in vivo after intravenous streptokinse in patients with acute myocardial infarction. Circulation 1988; 77: 142–150
   PubMed Web of Science ®Google Scholar
• Folts J D, Crowell E B, Rowe G G. Platelet aggregation in partially obstructed vessels and their elimination with aspirin. Circulation 1976; 54: 365–370
   PubMed Web of Science ®Google Scholar
• Folts J D, Rowe G G. Epinephrine reverses aspirin inhibition of in vivo platelet thrombus formation in stenosed dog coronary arteries. Thromb Res 1988; 50: 507–516
   PubMed Web of Science ®Google Scholar
• Folts J D, Bonebrake F C. The effects of cigarette smoke and nicotine on platelet plugging in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982; 65: 465–469
   PubMed Web of Science ®Google Scholar
• Folts J D. Experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance. Cardiovasc Rev Rep 1982; 3: 370–382
   Google Scholar
• Ashton J, Olgetree M L, Michel I M, et al. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary stenoses. Circulation 1987; 76: 952–959
   PubMed Web of Science ®Google Scholar
• Coller B S, Smith S R, Scudder L E, Jordan R, Folts J D. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor: Correlation with bleeding time, platelet aggregation and blockade of GPIIb/IIIa receptors. Circulation 1989
   Google Scholar
• Born G V R, Cross M J. The aggregation of blood platelets. J Physiol (Lond) 1963; 168: 178–195
   Google Scholar
• Read M S, Shermer R W, Brinkhous K M. Venom coagglutinin: An activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514–4518
   PubMed Web of Science ®Google Scholar
• Fujimura Y, Holland L Z, Ruggeri Z M, Zimmerman T S. The von Willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728. Blood 1980; 70: 985–988
   Google Scholar
• Coller B S, Folts J D, Scudder L E, Smith S R. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood 1986; 68: 783–786
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Gonias S L, Pizzo S V. The temperature dependent reaction between α2-macroglobulin and streptokinase-plasmin(ogen) complex. J Biol Chem 1987; 262: 3660–3664
   Google Scholar
• Bush L R, Campbell W B, Buja L M, Tilton G D, Willerson J T. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in coronary blood flow in stenosed canine coronary arteries. Circulation 1984; 69: 1161–1170
   Google Scholar
• Eidt J F, Allison P, Noble S, et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1989; 84: 18–27
   PubMed Web of Science ®Google Scholar
• Harker L A, Slichter S J. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287: 155–159
   PubMed Web of Science ®Google Scholar
• Golino P, Ashton J H, McNatt J, et al. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. Circulation 1989; 79: 911–919
   PubMedGoogle Scholar
• Shebuski R J, Stabilto I J, Sitko G R, Polokoff M H. Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis. Circulation 1990; 82: 169–177
   Google Scholar
• Rudd M A, George D, Amarante P, Vaughan D E, Loscalzo J. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins. Circ Res 1990, in press
   Google Scholar
• Loscalzo J, Vaughan D E. Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987; 79: 1749–1755
   Google Scholar
• Schafer A I, Rodriguez R, Loscalzo J, Gimbrone M A, Jr. Inhibition of vascular endothelial cell prostacyclin synthesis by plasmin. Blood 1989; 74: 1015–1020
   Google Scholar
• Bertha B G, Folts J D. Inhibition of epinephrine exacerbated coronary thrombus formation by PGI2 in the dog. J Lab Clin Med 1984; 2: 204–214
   Google Scholar
• Vaughan D E, Plavin S R, Schafer A I, Loscalzo J. Prostaglandin E1 accelerates thrombolysis by tissue plasminogen activator. Blood 1989; 73: 1213–1217
   Google Scholar